Step 1 topics → Microbiology → Non-Tuberculous Mycobacteria

Non-Tuberculous Mycobacteria

USMLE Step 1 trap: Confuses the CD4 <50 threshold for MAC prophylaxis with the CD4 <200 threshold for PCP prophylaxis. MAC prophylaxis with azithromycin is initiated when CD4 count falls below 50 cells/µL, while PCP prophylaxis begins below 200 cells/µL.

Non-tuberculous mycobacteria (NTM) is a category you really only need to know two members of for USMLE Step 1: M. avium complex (MAC) and M. leprae. The leprosy immunology is the classic trap — students assume the worse-looking disease (lepromatous) must reflect a stronger immune response, but it's the opposite: lepromatous leprosy means the Th1 cell-mediated response has essentially failed, leading to a sky-high bacterial burden and diffuse bilateral lesions. Tuberculoid leprosy is the form with strong Th1 immunity, few organisms, and limited well-defined lesions. For MAC, the key anchor is CD4 <50 for prophylaxis with azithromycin — distinct from the CD4 <200 threshold for PCP.

What makes this topic tricky is that students blur MAC with other AIDS-defining opportunistic infections. PCP, toxo, and MAC all happen at different CD4 thresholds, and the exam loves to test exactly that. The other major trap is leprosy: students often get the immunology backwards, assuming the worse-looking disease (lepromatous) must mean a stronger immune response. It's the opposite. Lepromatous leprosy = weak cell-mediated immunity = high bacterial burden = diffuse, widespread lesions. Tuberculoid leprosy = strong Th1 response = low bacterial load = few, well-defined lesions.

USMLE Step 1 will present these as vignettes. MAC typically shows up as an HIV patient with very low CD4 count, fever, drenching night sweats, weight loss, and an elevated alkaline phosphatase — a disseminated picture, not just a lung infection. Leprosy questions often give you histology or a description of skin lesions and nerve involvement, then ask you to match the presentation to the correct immunological profile. Nail the CD4 thresholds and the Th1/Th2 framework and you'll handle most of what the exam throws at you here.

From real student decks
68%have cards covering this topic
54%have mature cards
1median lapses in 14 days

Common misconceptions

Common mistake
Wrong: MAC prophylaxis in HIV is initiated at the same CD4 threshold as PCP prophylaxis (<200 cells/µL).
Right: MAC prophylaxis with azithromycin is initiated when CD4 count falls below 50 cells/µL, while PCP prophylaxis begins below 200 cells/µL.
PCP prophylaxis at CD4 <200 and MAC prophylaxis at CD4 <50 are two separate thresholds separated by a factor of four — they are not interchangeable. MAC requires a far more profoundly immunosuppressed state before it becomes a dominant opportunistic threat. On the exam, if the vignette gives you a CD4 of 150, the patient needs PCP prophylaxis but not yet MAC prophylaxis; if the CD4 is 40, both apply. Anchor MAC to the number 50 and PCP to 200.
Common mistake
Wrong: Lepromatous leprosy represents a strong cell-mediated immune response to M. leprae.
Right: Lepromatous leprosy reflects a weak Th1 (cell-mediated) response with high bacterial load and diffuse skin lesions, while tuberculoid leprosy reflects a strong Th1 response with few, well-defined lesions.
The worse the clinical picture in leprosy, the weaker the immune response — this is counterintuitive but essential. Lepromatous leprosy has a sky-high bacterial load and diffuse, bilateral, symmetric skin involvement precisely because the Th1 (cell-mediated) response has essentially failed; the body cannot contain the organism. Tuberculoid leprosy looks milder clinically — few, well-demarcated hypopigmented lesions with sensory loss — because the strong Th1 response limits bacterial spread even though it causes local granulomatous damage. Lepromatous = lots of bugs, weak CMI. Tuberculoid = few bugs, strong CMI.
Common mistake
Gap: Missing that MAC in advanced AIDS causes disseminated systemic disease rather than isolated pulmonary infection
In AIDS patients with CD4 <50, MAC causes disseminated infection (not localized pulmonary disease) presenting with fever, night sweats, weight loss, and elevated alkaline phosphatase from hepatic involvement.
In healthy or mildly immunocompromised patients, MAC can cause pulmonary disease (including hot tub lung), but in AIDS patients with CD4 below 50, the organism disseminates hematogenously throughout the reticuloendothelial system. This means the liver, spleen, and bone marrow are all involved, producing a systemic inflammatory picture — persistent fever, drenching night sweats, weight loss, anemia, and a markedly elevated alkaline phosphatase. If you see that ALP elevation paired with constitutional symptoms in a patient with advanced HIV, think disseminated MAC, not liver metastases or hepatitis.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the specific CD4 count threshold (<50 cells/µL) at which MAC prophylaxis with azithromycin is started in HIV patients, and distinguish it from the CD4 <200 threshold used for PCP prophylaxis.
  2. Recognize the clinical presentation of disseminated MAC in advanced AIDS: fever, night sweats, weight loss, and elevated alkaline phosphatase reflecting hepatic involvement — not a localized pulmonary infection.
  3. Distinguish tuberculoid from lepromatous leprosy based on the strength of the cell-mediated (Th1) immune response, the bacterial load, and the appearance and distribution of skin lesions.
  4. Apply the Th1/Th2 framework to leprosy: understand that lepromatous leprosy reflects a failed CMI response with high bacillary burden, while tuberculoid leprosy reflects a robust Th1 response that contains but does not eliminate the infection.

Can you avoid these mistakes?

An HIV-positive patient with a CD4 count of 35 cells/µL presents with 3 weeks of fever, night sweats, 10-pound weight loss, and labs showing elevated alkaline phosphatase and anemia. What organism is most likely responsible, and what drug is used for prophylaxis against this organism in this patient population?
A patient with leprosy has numerous diffuse, bilateral skin nodules with a high density of acid-fast bacilli on skin biopsy. A second patient has three hypopigmented, well-defined skin patches with decreased sensation and very few bacilli on biopsy. Which patient has a stronger Th1 cell-mediated immune response, and what is each patient's diagnosis?
An HIV-positive patient with a CD4 of 160 asks whether she needs any prophylaxis medications. She is not currently on ART. What do you prescribe, what organism does it cover, and what additional medication would she need if her CD4 dropped to 40?
Why does disseminated MAC in advanced AIDS cause an elevated alkaline phosphatase, and how does this presentation differ from MAC lung disease seen in immunocompetent patients (e.g., hot tub lung)?

Related topics

Mycobacterium tuberculosis Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →